Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$209.01 - $232.56 $446,654 - $496,980
2,137 New
2,137 $466,000
Q1 2023

May 12, 2023

BUY
$213.32 - $257.83 $711,635 - $860,120
3,336 Added 164.99%
5,358 $1.23 Million
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $2.05 Million - $2.5 Million
-10,048 Reduced 83.25%
2,022 $475,000
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $1.87 Million - $2.4 Million
-9,153 Reduced 43.13%
12,070 $2.47 Million
Q2 2022

Aug 12, 2022

BUY
$213.86 - $277.87 $1.05 Million - $1.36 Million
4,892 Added 29.96%
21,223 $4.97 Million
Q1 2022

May 12, 2022

BUY
$259.82 - $298.18 $230,460 - $264,485
887 Added 5.74%
16,331 $4.31 Million
Q4 2021

Feb 11, 2022

SELL
$271.6 - $314.21 $4.15 Million - $4.81 Million
-15,296 Reduced 49.76%
15,444 $4.85 Million
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $8.45 Million - $9.48 Million
30,740 New
30,740 $8.65 Million
Q2 2021

Aug 13, 2021

SELL
$251.87 - $278.14 $885,323 - $977,662
-3,515 Closed
0 $0
Q1 2021

May 06, 2021

BUY
$204.88 - $255.03 $720,153 - $896,430
3,515 New
3,515 $896,000
Q3 2020

Nov 13, 2020

SELL
$167.03 - $201.3 $1.47 Million - $1.77 Million
-8,800 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$113.31 - $182.44 $997,128 - $1.61 Million
8,800 New
8,800 $1.46 Million
Q1 2020

May 14, 2020

SELL
$104.32 - $195.28 $1.01 Million - $1.88 Million
-9,646 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$163.48 - $173.61 $1.58 Million - $1.67 Million
9,646 New
9,646 $1.63 Million
Q2 2019

Aug 14, 2019

SELL
$144.16 - $172.9 $1.31 Million - $1.57 Million
-9,054 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$123.7 - $156.3 $75,457 - $95,343
-610 Reduced 6.31%
9,054 $1.39 Million
Q4 2018

Feb 12, 2019

BUY
$120.82 - $174.09 $1.17 Million - $1.68 Million
9,664 New
9,664 $1.22 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.